TRT and fertility — what men under 40 need to know.

What TRT actually does to your sperm

The mechanism is well-understood. Your body controls testosterone through a feedback loop called the hypothalamic-pituitary-gonadal (HPG) axis. The hypothalamus releases GnRH (gonadotropin-releasing hormone) in pulses; the pituitary responds by releasing LH (luteinizing hormone) and FSH (follicle-stimulating hormone); LH tells your testes to produce testosterone, and FSH supports sperm production.

When you inject exogenous testosterone, the hypothalamus senses high testosterone in your bloodstream and stops sending GnRH pulses. LH and FSH drop. Your testes — without their signaling — stop producing both endogenous testosterone and sperm. This is the negative feedback loop and it's the entire reason TRT works the way it does.

Timeline of suppression

• Weeks 1–6: Endogenous LH/FSH suppression begins. Testicular volume may start decreasing.
• Months 2–6: Sperm count drops substantially. Many men reach severe oligospermia (very low sperm count); some reach azoospermia (no detectable sperm).
• Months 6+: If azoospermia hasn't occurred by 6 months on standard TRT doses, it's less likely to.

Recovery timeline (after stopping TRT)

The largest meta-analysis of recovery from contraceptive-dose testosterone (PMC 2016) found:

• Median 6 months from stopping to a sperm concentration of 20 million/mL
• ~67% of men recover within 6 months; ~90% within 12 months; ~95% within 24 months
• ~5% never fully recover baseline parameters — particularly men who used TRT for many years, started at older ages, or had pre-existing fertility issues

Your four options

The protocol that's right for you depends on three things: how severe your hypogonadism is (primary vs. secondary), how soon you want children, and how aggressive you want to be about preserving fertility while treating low T.

Option 1 — Enclomiphene (or clomiphene) monotherapy

Enclomiphene is a selective estrogen receptor modulator (SERM). It blocks estrogen feedback at the pituitary, which tricks your body into producing more LH and FSH — which raises your own testosterone production while keeping the sperm-producing signal intact.

Who it's appropriate for

Men with secondary hypogonadism — low T because the signal from the pituitary is weak, not because the testes themselves have failed. You can identify candidates from baseline labs: low total testosterone plus low or low-normal LH/FSH means there's a functional pituitary signal to amplify. See our bloodwork guide for what these markers mean.

Limitations

• Off-label use — enclomiphene is FDA-approved for female infertility, not male hypogonadism. Most prescriptions come from a compounding pharmacy.
• Less efficacious for primary hypogonadism — if your testes themselves are failing, no amount of pituitary signaling will help.
• Mood and visual side effects have been reported, though less commonly than with clomiphene.
• May not fully resolve symptoms for men with severely low baseline testosterone.

Cost

Typically $60–$150/month from a compounding pharmacy. Discussed during your consult if it fits your profile.

Option 2 — TRT + HCG

Human chorionic gonadotropin (HCG) is the most well-established fertility-preserving add-on. HCG mimics LH — binding to the same receptors in your testes that LH normally would — which keeps your intratesticular testosterone production going even while exogenous TRT suppresses your pituitary signal.

How it works mechanically

This matters: HCG works downstream at the testis itself. Your pituitary is still suppressed by the exogenous testosterone, but HCG bypasses that by directly stimulating the Leydig cells. The result is preserved intratesticular testosterone and largely preserved spermatogenesis.

Dosing and protocol

Typical dosing is 500–1,000 IU subcutaneously, 2–3 times per week, alongside your weekly testosterone cypionate. It's a separate injection (a tiny subcutaneous one) — not an addition to your testosterone vial.

HCG availability in Massachusetts

HCG has had supply challenges since the early 2020s. In Massachusetts it's typically sourced from a 503A compounding pharmacy under a physician's prescription. Brand-name FDA-approved HCG (Pregnyl) has variable availability; compounded HCG is the more common form for TRT use.

Option 3 — TRT + gonadorelin

Gonadorelin is a synthetic version of GnRH — the upstream hormone that tells your pituitary to release LH and FSH. Several TRT clinics adopted gonadorelin as an HCG alternative during the HCG supply issues of 2020–2022.

The critical caveat

Gonadorelin works upstream at the pituitary. But your pituitary is already suppressed by exogenous testosterone. The same negative feedback that suppresses your natural LH/FSH also blunts your pituitary's response to gonadorelin. This is why a growing number of clinicians — including AlphaMD and Full Potential Men — argue gonadorelin does not reliably preserve intratesticular testosterone the way HCG does.

When gonadorelin may still be appropriate

• Testicular volume maintenance (cosmetic + comfort) without primary fertility goals
• Men who can't tolerate HCG due to estrogen-related side effects
• Patients who prefer the simpler dosing schedule

Option 4 — Sperm banking before starting TRT

The simplest, most robust insurance policy: bank sperm before you start. Even if you also use HCG or gonadorelin, banking removes the small but real risk of permanent suppression. We recommend this to almost every patient under 35 and to most patients between 35 and 40.

How it works

1. Initial consultation and semen analysis at a Massachusetts fertility clinic ($200–$500).
2. Sample collection — typically 2–3 samples over 2 weeks for adequate volume.
3. Cryopreservation — samples are frozen and stored indefinitely. Storage runs $200–$500/year depending on facility.

Massachusetts options

Several MA reproductive endocrinology practices and sperm banks offer this — Boston IVF, Reproductive Science Center, Fairfax Cryobank (with collection sites in MA). We can refer you and coordinate timing with your TRT start.

How Tier 1 TRT approaches the fertility conversation

Every patient under 40 — and most patients 40–50 — gets an explicit fertility discussion at the intake visit. Not an upsell, not a checkbox. A conversation about your timeline, your situation, and what the right protocol looks like.

The decision tree we use

1. Are you actively trying to conceive in the next 6–12 months? If yes — we don't start TRT. We refer you to a reproductive endocrinologist and revisit after.
2. Do you have low LH/FSH alongside low T? If yes — enclomiphene monotherapy is on the table.
3. Do you want kids someday, even if not soon? If yes — we discuss HCG add-on as the default fertility-preserving protocol, and recommend sperm banking before starting.
4. Do you have completed family planning? If yes — standard TRT without add-ons is usually appropriate, with the patient understanding that recovery isn't guaranteed if they ever want to restart fertility years from now.

For Massachusetts patients who need reproductive endocrinology referrals, we coordinate with established MA practices and can sequence intake, banking, and TRT start across providers.

Frequently asked questions

Keep reading